We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vaccine Social Media Randomized Intervention Trial (VSMRCT)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01873040
First Posted: June 7, 2013
Last Update Posted: October 18, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Agency for Healthcare Research and Quality (AHRQ)
Information provided by (Responsible Party):
Kaiser Permanente
  Purpose

This study will assess the effectiveness of social media website devoted to vaccines to change immunization knowledge, perceptions and behavior. If effective, this intervention will represent an innovative, low cost and broadly applicable resource to reduce parental vaccination concerns.

The study has two hypothesis:

  1. Parents receiving usual care plus social media website will demonstrate higher early childhood immunization rates to parents receiving either usual plus non interactive website or usual care only.
  2. Parents receiving usual care plus social media website will demonstrate positive changes in knowledge, attitudes and beliefs supporting vaccination compared to parents receiving either usual care plus non-interactive website or usual care only.

Condition Intervention
Communicable Diseases Behavioral: Social Media plus information pages Behavioral: Vaccine Information Pages

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Randomized Intervention Trial to Evaluate a Vaccine Social Media Website

Further study details as provided by Kaiser Permanente:

Primary Outcome Measures:
  • Days under-immunized [ Time Frame: 2 years ]
    Days under-immunized is a metric to identify immunization delay. For each vaccine dose calculate the difference between when the vaccine dose was actually administered and when the vaccine dose should have been administered according to the Advisory Committee on Immunization Practices (ACIP) schedule. That difference is summed across all doses and vaccines for a total number of days under-immunized for each child. Total days under immunized was calculated 200 days after life or after enrollment. If someone had 0 days at that time they were considered "up to date".


Secondary Outcome Measures:
  • Knowledge, Attitudes and Beliefs about immunizations [ Time Frame: Baseline, Child age 3-5 months, Child age 12-15 months ]
    Knowledge, attitudes, and beliefs will be measured with a survey at up to 3 time points during the study: 1) Initial enrollment in the study, 2) child's ag=4-6 months and 3) child's age=11-13 months.


Enrollment: 1675
Study Start Date: August 2013
Study Completion Date: November 2016
Primary Completion Date: November 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Social media plus information pages
Participants will have access to the vaccine social media website with information pages and social media features including discussion forums, blogs, chat with an expert, and ask an expert.
Behavioral: Social Media plus information pages
Participants will receive access to the study vaccine website information pages and social media feature including blogs, discussion forums, expert chats, and ask an expert.
Experimental: Information Pages
Participants will have website access to vaccine information pages.
Behavioral: Vaccine Information Pages
Participants will receive access to the study vaccine website information pages.
No Intervention: Usual Care
Participants will not have access to the vaccine website. They will receive pediatric care as usual.

Detailed Description:
Participants will be enrolled in the study, stratified based on hesitancy and randomly assigned to 1 of 3 study arms and followed for 1-2 years.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Women >20 weeks Pregnant (including parents of children up to 1 year of age).
  • >18 years of age

Exclusion Criteria:

  • Non english speak
  • Do not intend to use Kaiser insurance for the child
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01873040


Locations
United States, Colorado
Kaiser Permanente Colorado Institute for Health Research
Denver, Colorado, United States, 80231
Sponsors and Collaborators
Kaiser Permanente
Agency for Healthcare Research and Quality (AHRQ)
Investigators
Principal Investigator: Jason M Glanz, PhD Kaiser Permanente
  More Information

Responsible Party: Kaiser Permanente
ClinicalTrials.gov Identifier: NCT01873040     History of Changes
Other Study ID Numbers: 1R01HS021492-01 ( U.S. AHRQ Grant/Contract )
First Submitted: June 5, 2013
First Posted: June 7, 2013
Last Update Posted: October 18, 2017
Last Verified: October 2017

Keywords provided by Kaiser Permanente:
Social Media
Vaccine
Immunization

Additional relevant MeSH terms:
Communicable Diseases
Infection
Vaccines
Immunologic Factors
Physiological Effects of Drugs